Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

BEVQOLVA DIN 02567865

Status: Approved
Holder: CURATEQ BIOLOGICS PRIVATE LIMITED
Molecule: BEVACIZUMAB

Health Canada record

Active ingredient(s)BEVACIZUMAB 400 MG
Dosage formSolution
RouteIntravenous
ScheduleSCHEDULE D; PRESCRIPTION
ClassHuman
ATCL01FG01 BEVACIZUMAB
Original market date
Current status date28-Apr-2026
SourceHealth Canada DPD

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing BEVACIZUMAB

DINProductCompanyFormStrengthStatus
02522160ABEVMYBIOCON BIOLOGICS CANADA INCSolutionBEVACIZUMAB 400 MGMarketed
02522179ABEVMYBIOCON BIOLOGICS CANADA INCSolutionBEVACIZUMAB 100 MGMarketed
02270994AVASTINHOFFMANN-LA ROCHE LIMITEDSolutionBEVACIZUMAB 25 MGMarketed
02522837AYBINTIOSAMSUNG BIOEPIS CO., LTDSolutionBEVACIZUMAB 400 MGMarketed
02522829AYBINTIOSAMSUNG BIOEPIS CO., LTDSolutionBEVACIZUMAB 100 MGMarketed
02520729BAMBEVIAPOTEX INCSolutionBEVACIZUMAB 100 MGMarketed
02520737BAMBEVIAPOTEX INCSolutionBEVACIZUMAB 400 MGMarketed
02567830BEVQOLVACURATEQ BIOLOGICS PRIVATE LIMITEDSolutionBEVACIZUMAB 100 MGApproved
02470748MVASIAMGEN CANADA INCSolutionBEVACIZUMAB 25 MGMarketed
02470756MVASIAMGEN CANADA INCSolutionBEVACIZUMAB 25 MGMarketed
02534177VEGZELMACELLTRION INC.SolutionBEVACIZUMAB 100 MGMarketed
02534185VEGZELMACELLTRION INC.SolutionBEVACIZUMAB 400 MGMarketed
02489430ZIRABEVPFIZER CANADA ULCSolutionBEVACIZUMAB 100 MGMarketed
02489449ZIRABEVPFIZER CANADA ULCSolutionBEVACIZUMAB 400 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
374502026-04-28New Drug Submission (NDS)
Request a quote for BEVQOLVA

How to read a Canadian DIN record